Home / Guides / Took too much tirzepatide
Who to call, in order.
Took too much tirzepatide? What to do right now
By the NexLife Medical Team · Medically reviewed by Adam Kennah, MD · Updated
If you took too much tirzepatide, call 911 for an emergency; otherwise call Poison Control at
- Who to call, in order: the five steps below
An emergency? Call 911 now
Otherwise, call Poison Control: free, confidential, 24/7. Then call your prescriber.
NexLife patients: after those calls, never instead, call or text us. Real people answer 24/7.
This page follows the FDA-approved Zepbound and Wegovy labels and the FDA’s reports on compounded
At a glance
Took too much tirzepatide? What to do, in order
Not sure how serious it is? Call.
| Question | Answer |
|---|---|
| An emergency? | Call 911 for trouble breathing, a swollen face or throat, fainting, confusion, a seizure, severe dehydration or severe low blood sugar. |
| Otherwise? | Call Poison Control at |
| What should you have ready? | The vial and syringe: the strength in mg per mL, the units or mL you drew, when you injected, and any diabetes medicines you take. |
| How long can it last? | Zepbound’s label gives no set time: observation and treatment may be needed, taking into account tirzepatide’s half-life of about 5 days. |
| When is your next dose? | Ask your prescriber first. Only a clinician who knows your history should decide when, and how much. |
| A NexLife patient? | After 911 or Poison Control, never instead, call or text |
Key takeaways
- Took too much? Call 911 for an emergency. Otherwise, call Poison Control, free and 24/7, at
1-800-222-1222 , then your prescriber. - Emergencies include trouble breathing, a swollen face or throat, fainting, confusion, a seizure, severe dehydration or severe low blood sugar.
- Zepbound’s label says observation and treatment may be needed, taking into account tirzepatide’s half-life of about 5 days.
- Ask your prescriber before your next dose. Only a clinician who knows your history should decide when, and how much.
- In FDA reports, most errors mix up units, mL and mg, like 50 units of compounded semaglutide drawn where 5 were meant.
- NexLife patients: after 911 or Poison Control, never instead, call or text
(949) 818-8000 , 24/7.
Right now
What should you do right now, step by step?
Call first; read later. Do these five steps in order: the first three are calls. Poison Control’s number was checked November 1, 2026.
An emergency? Call 911
Trouble breathing or swallowing, swelling of your face, lips, tongue or throat, fainting, confusion, severe dehydration or severe low blood sugar. The details are just below.
Otherwise, call Poison Control: 1-800-222-1222
It’s free and confidential, open 24 hours a day, every day, and answered by specialists including nurses, pharmacists and physicians, America’s Poison Centers says. The Zepbound and Wegovy labels both name this line for overdoses.
Then call your prescriber
Zepbound’s Medication Guide says that if you take too much, call your healthcare provider or Poison Help, or go to the nearest hospital emergency room right away.
Keep the vial and syringe with you
The strength on the label in mg per mL, how many units or mL you drew, when you injected, and any diabetes medicines you take all help whoever you call.
Ask before your next dose
Only a clinician who knows your history should decide when your next dose is, and how much.
The same five steps, in order. Your prescriber’s and Poison Control’s advice come first.
NexLife patients: after 911 or Poison Control, never instead, call or text
Emergency
When is it an emergency? Call 911 for these
Call 911 for trouble breathing or swallowing, swelling of your face, lips, tongue or throat, fainting, confusion or a seizure, severe dehydration, or severe low blood sugar. These need emergency care now. Call 911, or have someone take you to the nearest emergency room; don’t drive yourself. Not sure? Call 911.
- Trouble breathing or swallowing, or swelling of your face, lips, tongue or throat
- Fainting, or being hard to wake
- Confusion, or a seizure
- Signs of severe dehydration, such as little or no urine, dizziness or a racing heartbeat, especially if you can’t keep fluids down
- Severe low blood sugar: confusion, being hard to wake, not being able to eat or drink, or symptoms that don’t improve after you eat or drink something with sugar
Call Poison Control and your prescriber right away for these
- Severe stomach pain that won’t go away, with or without vomiting. Zepbound’s Medication Guide says to stop the medicine and call your healthcare provider right away; it can be a sign of pancreatitis.
- Nausea, vomiting or diarrhea that doesn’t go away. Tell your prescriber right away, the guide says, and keep sipping fluids.
- Signs of low blood sugar while you’re alert, such as shakiness, sweating, hunger, a headache or a fast heartbeat. Treat it the way your provider showed you, then tell them. It’s more likely if you also take insulin or a sulfonylurea.
- Pain in your upper stomach, yellow skin or eyes, fever or clay-colored stools, which the guide lists as possible gallbladder problems. Tell your prescriber right away.
Where these come from. The emergency signs follow two sources. Zepbound’s Medication Guide says to get medical help right away for a serious allergic reaction. MedlinePlus, the National Library of Medicine’s guide, sends confusion, loss of consciousness and low blood sugar that doesn’t improve with sugar to 911. The second list is the Medication Guide’s own advice. Not sure? Call 911 if you think it may be an emergency; otherwise, Poison Control can advise you.
The labels
What do the Zepbound and Wegovy labels say about an overdose?
Both labels, read November 1, 2026, say to contact the Poison Help line at
“In the event of an overdosage, contact the Poison Help Line (
Eli Lilly and Company, Zepbound (tirzepatide) prescribing information, section 10, Overdosage (revised August 2026)1-800-222-1222 ) or a medical toxicologist for additional overdosage management recommendations. Appropriate supportive treatment should be initiated according to the patient’s clinical signs and symptoms. A period of observation and treatment for these symptoms may be necessary, taking into account the half-life of tirzepatide of approximately 5 days.”
| In an overdose | Zepbound (tirzepatide) | Wegovy (semaglutide) |
|---|---|---|
| Who to contact | The Poison Help line (1-800-222-1222) or a medical toxicologist | Consider the Poison Help line (1-800-222-1222) or a medical toxicologist |
| Effects reported | Not listed in this section | With |
| Treatment | Supportive treatment, based on your signs and symptoms | Supportive treatment, based on your signs and symptoms |
| How long to watch | Observation and treatment may be needed: the half-life is about 5 days | A prolonged period may be needed: the half-life is about 1 week |
Swipe the table sideways to see every column.
The overdosage sections of the Zepbound prescribing information (revised August 2026) and the Wegovy prescribing information (revised June 2026), read November 1, 2026. They describe FDA-approved Zepbound and Wegovy; compounded tirzepatide and semaglutide aren’t FDA-approved, so no FDA label describes them.
For patients, Zepbound’s Medication Guide puts it plainly: call your healthcare provider or Poison Help at
FDA reports
What has the FDA seen with compounded GLP-1 overdoses?
Dosing errors, mostly from mixing up units, mL and mg. In a July 26, 2024 alert, the FDA reported people taking 5 to 20 times their intended dose of compounded semaglutide. Some drew 50 units where 5 were meant. Some needed hospital care. Check your units against your label every time.
“In these instances, patients administered five to 20 times more than the intended dose of semaglutide.”
The FDA reports overdoses of compounded semaglutide at 5 to 20 times the intended dose. In several, patients told to draw 5 units (0.05 mL) on a U-100 syringe drew 50 units (0.5 mL). Some health care providers miscalculated doses when converting milligrams to units or milliliters, giving 5 to 10 times the intended dose. Reported effects: nausea, vomiting, abdominal pain, fainting, headache, migraine, dehydration, acute pancreatitis and gallstones; some people needed hospital care.
By this date, the FDA had received 990 adverse event reports with compounded semaglutide and more than 730 with compounded tirzepatide, from all causes, not only dosing errors.
The FDA’s
GLP-1 page, updated this day, also lists reports that may be linked to compounded semaglutide or tirzepatide prescribed beyond what the approved drugs’ labels allow. That could mean more in one dose, doses more often or faster increases. Some people sought medical care for nausea, vomiting, diarrhea, abdominal pain or constipation.
Why vials need extra care. A pen measures the dose for you. With any vial, including the multi-dose vials listed on Zepbound’s August 2026 label, you measure each dose yourself with a syringe. The FDA reports above involve compounded products. Compounded tirzepatide and semaglutide aren’t FDA-approved, so the FDA doesn’t review them for safety, effectiveness or quality before they’re sold. Other compounded risks, from add-ins to storage: what’s different about compounded tirzepatide.
Mix-ups
How do dose mix-ups happen with compounded vials?
One dose is described by three numbers: milligrams, the vial’s strength in mg per mL, and the units or mL your syringe measures. The FDA’s reports trace most errors to mixing those up. On a U-100 syringe, 100 units is 1 mL, so 0.1 mL is 10 units, not 1. A new vial strength changes your units.
Milligrams (mg)
How much medicine is in your dose. Your prescription sets it; only your provider changes it.
Milligrams per mL (mg/mL)
How strong the vial is. It’s printed on the label, and it can differ from one vial to the next.
Units and mL
What the syringe measures. On a U-100 insulin syringe, 100 units is 1 mL, so 1 unit is 0.01 mL, and 0.1 mL is 10 units, not 1.
Syringe size
A 0.3 mL syringe holds 30 units, a 0.5 mL syringe 50 and a 1 mL syringe 100, and a 1 mL syringe’s lines usually mark 2 units, not 1. The FDA describes patients given syringes much larger than their dose.
50 units on a U-100 syringe is 0.5 mL. How much medicine that holds depends on the vial’s strength, so give your provider the milligrams on your label, not the units.
Recheck every new vial. If its strength differs from your last one, the same number of units gives a different dose. Our tirzepatide dosage chart and semaglutide dosage chart show the math; your prescription, not a chart, sets your dose.
Check the math
How do you check how much tirzepatide you drew?
The math: mL = your dose in mg ÷ your vial’s strength in mg per mL, and units = mL × 100 on a U-100 syringe. The table uses 25 mg per mL as an example only: your vial’s label decides.
| Dose | Volume at 25 mg/mL | Units (U-100) |
|---|---|---|
| 2.5 mg | 0.1 mL | 10 units |
| 5 mg | 0.2 mL | 20 units |
| 7.5 mg | 0.3 mL | 30 units |
| 10 mg | 0.4 mL | 40 units |
| 12.5 mg | 0.5 mL | 50 units |
| 15 mg | 0.6 mL | 60 units |
Example only: your vial’s label decides, and your prescription sets your dose. Zepbound’s multi-dose vials hold each labeled dose in 0.6 mL, so their strength differs by vial; only the 15 mg vial is 25 mg per mL. Other vials, compounded ones included, can have other strengths. Or enter your own vial’s strength in the tirzepatide dosage calculator.
Injected more than your prescribed dose? Call 911 for an emergency; otherwise call Poison Control at
Before you inject
How can you check a dose before you inject?
Match three things every time: the vial’s strength in mg per mL, the dose on your prescription, and the units on your syringe. On many 1 mL syringes, each line is 2 units. If anything doesn’t match, don’t inject: call your pharmacy or prescriber first. The FDA encourages asking how to measure your dose.
Read the label
Find the vial’s strength in mg per mL, and the dose your prescription gives, in mg and in units if it lists them.
Match the syringe
Use the syringe your prescription came with, and count its markings: on many 1 mL syringes, each line is 2 units.
Doesn’t match? Stop
Don’t inject it. Call your pharmacy or your prescriber first.
Ask how to measure
The FDA encourages patients to ask their health care provider or compounder how to measure and give the intended dose. Ask again whenever the vial, the syringe or the dose changes.
“FDA encourages patients to talk with their health care provider or compounder about how to measure and administer the intended dose of compounded semaglutide.”
U.S. Food and Drug Administration, FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products, July 26, 2024
Step by step, with pictures: how to inject tirzepatide from a vial. Check the pharmacy and lot number too, against our compounded GLP-1 recall list.
Report it
Should you report a dosing mistake?
Yes, once you’re safe. The FDA asks patients, providers and compounders to report medication errors and side effects to its MedWatch program, online at fda.gov/medwatch or at
Once you’re safe, report the mistake and any side effects to the FDA’s MedWatch program, online at fda.gov/medwatch or by phone at
NexLife patients
For NexLife patients: how do you reach your prescriber?
Our line comes after 911 or Poison Control, never instead.
If NexLife prescribed your tirzepatide, step 3, calling your prescriber, means calling us:
Took too much: your questions
I took too much tirzepatide. What should I do?
Call 911 for an emergency; otherwise call Poison Control at
What happens if you take too much tirzepatide?
Effects of
How long does a tirzepatide overdose last?
Zepbound’s label gives no set time. It says a period of observation and treatment may be needed, taking into account tirzepatide’s half-life of about 5 days. How long depends on how much you took and on you, so follow Poison Control’s or your prescriber’s advice.
I accidentally took a double dose. What now?
Call Poison Control at
Is severe stomach pain after too much tirzepatide an emergency?
Call your prescriber right away: Zepbound’s Medication Guide says to stop the medicine and call your healthcare provider right away for severe stomach pain that won’t go away, with or without vomiting, because it can be a sign of pancreatitis. Call 911 if you also faint, become confused or show signs of severe dehydration.
Is Poison Control only for poisonings?
No. Both the Zepbound and Wegovy labels name the Poison Help line,
How many units is too many?
There’s no single number: units depend on your vial’s strength in mg per mL. On a U-100 syringe, 50 units is 0.5 mL, which holds 5 mg at 10 mg per mL but 10 mg at 20 mg per mL. Injected more than your prescribed dose? Call 911 for an emergency; otherwise call Poison Control at
Can you overdose on semaglutide?
Yes. Wegovy’s label lists severe nausea, severe vomiting and severe low blood sugar from
How do I avoid this happening again?
Check the strength on every new vial, use the syringe your prescription came with, and match what you draw to the dose on your label. If anything looks different, ask your pharmacy or prescriber before you inject. NexLife patients can call or text
Should you report a tirzepatide dosing mistake?
Yes, once you’re safe. Report the mistake and any side effects to the FDA’s MedWatch program, online at fda.gov/medwatch or by phone at 1-800-FDA-1088. Tell your prescriber and the pharmacy that filled your vial, too. Report after calling 911 or Poison Control, never instead.
Why do dosing mistakes happen with tirzepatide vials?
With a vial, you measure each dose yourself with a syringe, while a pen measures it for you. The FDA’s reports trace most errors to mixing up three numbers: milligrams, the vial’s strength in mg per mL and the units or mL your syringe measures.
What has the FDA reported about compounded GLP-1 overdoses?
In a July 26, 2024 alert, the FDA reported people taking 5 to 20 times their intended dose of compounded semaglutide; some drew 50 units where 5 were meant. Reported effects included nausea, vomiting, abdominal pain, fainting, dehydration, acute pancreatitis and gallstones; some people needed hospital care.
Important safety information
Compounded tirzepatide and semaglutide are not FDA-approved, and the FDA hasn’t reviewed them for safety, effectiveness or quality. A provider prescribes them only when they offer a significant difference for you compared with an FDA-approved product. Both medicines may cause thyroid tumors, including cancer: don’t use either if you or a family member has had medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2).
Read the full safety information
In studies with rodents, both medicines caused thyroid tumors; it isn’t known whether they cause them in people. Tell your provider if you notice a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath. Serious side effects can include inflammation of the pancreas (pancreatitis), gallbladder problems, low blood sugar (especially with insulin or sulfonylureas), kidney problems from dehydration, severe stomach problems, serious allergic reactions, vision changes in people with type 2 diabetes, and a faster heart rate. The FDA warned on Nov. 9, 2026, that GLP-1 medicines may raise the risk of NAION, a rare eye condition that can cause sudden vision loss in one eye; call your provider right away if that happens (FDA). Tell your care team before any surgery or procedure that uses anesthesia or deep sedation. Don’t combine either medicine with other
Tirzepatide can make birth control pills less effective: switch to a non-oral method, or add a barrier method such as condoms, for 4 weeks after you start and for 4 weeks after each dose increase. Both medicines may harm an unborn baby. Semaglutide should be stopped at least 2 months before a planned pregnancy. Tell your provider right away if you’re pregnant, planning to be, or breastfeeding.
This is a summary, not the complete safety information. Read the full Prescribing Information for FDA-approved tirzepatide (Zepbound) and semaglutide (Wegovy), and talk with your provider. You can report side effects to the FDA at
About NexLife. NexLife is a telehealth and care-coordination platform. Care is delivered through affiliated, physician-owned medical groups, and licensed providers decide whether treatment is right for you. NexLife doesn’t make or compound medication: state-licensed partner pharmacies fill each prescription, and we coordinate the rest. Available only in states where our affiliated providers are licensed.
Who wrote and medically reviewed this page?
Leads the NexLife Medical Team, which writes and medically reviews NexLife’s guides, including this one.
The labels, the FDA’s reports and Poison Control’s number checked November 1, 2026.
- How we checked. What to do, and in what order, follows the Zepbound and Wegovy labels’ overdose sections and Zepbound’s Medication Guide; the emergency signs follow the Medication Guide and MedlinePlus. All read November 1, 2026. The dosing-error reports are the FDA’s own, with their dates; Poison Control’s number and hours come from America’s Poison Centers; the units math from our dosage charts. We don’t give a dose: your prescriber decides.
- Every fact, sourced. Each price and rule links to the page it comes from.
- How we make money. NexLife is a telehealth and care-coordination platform. We earn revenue when people join NexLife.
- Corrections, fast. See something wrong or out of date? Email hello@nexlife.us and we’ll fix it.
- How we work. How we review programs · GLP-1 price index · Is NexLife legit? · States NexLife serves
A real prescription. A fair price.
A licensed provider decides if treatment is right for you.
Medical director Adam Kennah, MD (NPI 1144260043) · LegitScript-certified
Compounded medications aren’t FDA-approved. A provider prescribes one only when it offers a significant difference for you.
Sources
- America’s Poison Centers: Poison Help, 1-800-222-1222. Checked November 1, 2026.
- HRSA: Poison Help, calling the Poison Help line. Checked November 1, 2026.
- Zepbound (tirzepatide) prescribing information, Eli Lilly (revised August 2026), section 10, Overdosage. Read November 1, 2026.
- Zepbound (tirzepatide) Medication Guide, Eli Lilly (revised August 2026). Read November 1, 2026.
- Wegovy (semaglutide) prescribing information, Novo Nordisk (revised June 2026), section 10, Overdosage; FDA’s copy. Read November 1, 2026.
- FDA: FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products (July 26, 2024). Read November 1, 2026.
- FDA: Concerns with unapproved
GLP-1 drugs used for weight loss (updated October 1, 2026). Read November 1, 2026. - MedlinePlus (National Library of Medicine): Dehydration (reviewed July 1, 2025). Read November 1, 2026.
- MedlinePlus: Low blood sugar (reviewed January 25, 2026). Read November 1, 2026.
- MedlinePlus: Low blood sugar, self-care (reviewed January 25, 2026). Read November 1, 2026.
- MedlinePlus: Nausea and vomiting, adults (reviewed July 22, 2025). Read November 1, 2026.
- NexLife: Compounded tirzepatide dosage chart. Read November 1, 2026.
- NexLife: Compounded semaglutide dosage chart. Read November 1, 2026.
- Eli Lilly and Company, on Drugs@FDA. Zepbound (tirzepatide) prescribing information, revised August 2026. Section 3 (the multi-dose vials’ strengths) and section 10, Overdosage. Read November 2, 2026.
- U.S. Food and Drug Administration. MedWatch: The FDA Safety Information and Adverse Event Reporting Program. Read November 2, 2026.